Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06201689 · ClinicalTrials.gov registry record · NA
Radicle Energy 24: A Study of Health and Wellness Products on Fatigue and Related Health Outcomes
A NA study of Fatigue and Energy, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 5,543
- Enrollment target
- 1
- Study location
NCT06201689: Completed NA study of Fatigue and Energy, sponsored by Radicle Science.
NCT06201689 is a NA study of Fatigue and Energy that has completed, run by Radicle Science. The registered enrollment target is 5,543 participants, above the 167-participant average among 109 other Fatigue trials with a reported enrollment target (3219% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06201689, a NA study of Fatigue and Energy, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,543 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on fatigue and related health outcomes
Primary Outcome
Mean difference in fatigue score as assessed by Patient Reported Outcome Measurement System (PROMIS) Fatigue 8A (scale 8-40; where higher scores correspond to more severe fatigue)
Interventions
- DIETARY_SUPPLEMENT Energy Placebo Control Form 1
- DIETARY_SUPPLEMENT Energy Active Study Product 1.1 Usage
- DIETARY_SUPPLEMENT Energy Active Study Product 1.2 Usage
- DIETARY_SUPPLEMENT Energy Placebo Control Form 2
- DIETARY_SUPPLEMENT Energy Active Study Product 2.1 Usage
Study Locations (1)
California
- Radicle Science, Inc - Del Mar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,543 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2025-07-10 |
| Phase | NA |
What the finished NCT06201689 record still lists
NCT06201689 is an interventional study that assigns participants to a tested intervention. Its 5,543 participants enrollment target places it among the larger protocols in the corpus, above the 167-participant average among 109 other Fatigue trials with a reported enrollment target (3219% higher).
The record links to 2 conditions, with Fatigue appearing as the primary indexed condition, and to 5 interventions - of which Energy Placebo Control Form 1 is the first listed.
NCT06201689 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06201689 about?
NCT06201689 is a clinical study titled "Radicle Energy 24: A Study of Health and Wellness Products on Fatigue and Related Health Outcomes". A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on fatigue and related health outcomes
What is the current status of trial NCT06201689?
This trial is currently completed. It is a NA study. The enrollment target is 5,543 participants. The study started on 2024-02-01. Estimated completion is 2025-07-10.
What conditions does trial NCT06201689 study?
This clinical trial studies the following conditions: Fatigue, Energy.
What interventions are being tested in trial NCT06201689?
The interventions under investigation include: Energy Placebo Control Form 1 (DIETARY_SUPPLEMENT), Energy Active Study Product 1.1 Usage (DIETARY_SUPPLEMENT), Energy Active Study Product 1.2 Usage (DIETARY_SUPPLEMENT), Energy Placebo Control Form 2 (DIETARY_SUPPLEMENT), Energy Active Study Product 2.1 Usage (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06201689?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06201689 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06201689's enrollment target sits among peer trials
5,543 1st of 109 higher than 109 of 109 other Fatigue trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fatigue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fatigue and Cognitive Demand With Aging
RECRUITING · NA
-
Behavioral and Neural Correlates of Post-Stroke Fatigue
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
RECRUITING · NA
-
Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07146568 · 5,515 participants · NA
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
- NCT06981598 · 5,586 participants · NA
Prevention of Psychological Health Problems Via Integrated Operational Support
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI